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Abstract
Background: Legionella pneumophila pneumonia often exacerbates acute lung injury (ALI) and acute respiratory distress
syndrome (ARDS). Apoptosis of alveolar epithelial cells is considered to play an important role in the pathogenesis of
ALI and ARDS. In this study, we investigated the precise mechanism by which A549 alveolar epithelial cells induced by L.
pneumophila undergo apoptosis. We also studied the effect of methyl prednisolone on apoptosis in these cells.
Methods: Nuclear deoxyribonucleic acid (DNA) fragmentation and caspase activation in L. pneumophila-infected A549
alveolar epithelial cells were assessed using the terminal deoxyribonucleotidyl transferase-mediated triphosphate
(dUTP)-biotin nick end labeling method (TUNEL method) and colorimetric caspase activity assays. The virulent L.
pneumophila strain AA100jm and the avirulent dotO mutant were used and compared in this study. In addition, we
investigated whether methyl prednisolone has any influence on nuclear DNA fragmentation and caspase activation in
A549 alveolar epithelial cells infected with L. pneumophila.
Results: The virulent strain of L. pneumophila grew within A549 alveolar epithelial cells and induced subsequent cell death
in a dose-dependent manner. The avirulent strain dotO mutant showed no such effect. The virulent strains of L.
pneumophila induced DNA fragmentation (shown by TUNEL staining) and activation of caspases 3, 8, 9, and 1 in A549
cells, while the avirulent strain did not. High-mobility group box 1 (HMGB1) protein was released from A549 cells
infected with virulent Legionella. Methyl prednisolone (53.4 μM) did not influence the intracellular growth of L.
pneumophila within alveolar epithelial cells, but affected DNA fragmentation and caspase activation of infected A549 cells.
Conclusion: Infection of A549 alveolar epithelial cells with L. pneumophila caused programmed cell death, activation of
various caspases, and release of HMGB1. The dot/icm system, a major virulence factor of L. pneumophila, is involved in
the effects we measured in alveolar epithelial cells. Methyl prednisolone may modulate the interaction of Legionella and
these cells.
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Background
The Legionnaires' disease bacterium, Legionella pneu-
mophila, is one of the most common etiologic agents of
bacterial pneumonia. This Gram-negative bacterium can
multiply within mononuclear cells in vivo and in vitro [1],
and evade phagosome-lysosome fusion within these cells
[2]. An important set of virulence factors expressed by L.
pneumophila is the dot/icm system, a type IV secretion sys-
tem that allows the organism to escape phagosome-lyso-
some fusion and to grow within the phagolysosome [3,4].
The ability of L. pneumophila to cause pneumonia is
dependent on its capacity to invade and replicate within
alveolar macrophages and monocytes [5]. In addition,
intracellular replication within alveolar epithelial cells
may contribute to the pathogenesis of Legionnaires' dis-
ease [5,6].
Legionella  pneumonia is a potentially serious and life-
threatening pneumonia [7,8]. It can exacerbate and
develop lethal complications, including acute lung injury
(ALI) and acute respiratory distress syndrome (ARDS), a
severe form of ALI [9,10]. ARDS is characterized by
flooded alveolar air spaces and increased microvascular
and epithelial permeability due to neutrophil inflamma-
tion, damage to the alveolar capillary endothelium, and
disruption of the alveolar epithelium [11,12]. Apoptotic
epithelial cells are found in the damaged alveolar epithe-
lium of patients with ARDS [13], implicating such a mech-
anism in the pathogenesis of ALI and ARDS, including
immune recovery and tissue repair after injury [12]. Apop-
tosis was also induced in L. pneumophila-infected alveolar
epithelial cells and, consequently, L. pneumophila is con-
sidered to play a key role in cytotoxicity [14]. However,
the apoptotic mechanisms operating in alveolar epithelial
cells remain largely unexplored.
This study confirmed the intracellular growth and cytotox-
icity of L. pneumophila in A549 alveolar epithelial cells. We
also investigated the mechanisms of apoptosis of L. pneu-
mophila-infected A549 cells, including nuclear deoxyribo-
nucleic acid (DNA) fragmentation and activation of
various caspases. In addition, we examined the release of
the high-mobility group box 1 (HMGB1) protein, a late
phase mediator of acute lung inflammation [15], from
Legionella-infected alveolar epithelial cells. We also used
the avirulent dotO mutant strain of L. pneumophila lacking
a functional dot/icm secretion system [5] to identify bac-
terial trigger factor(s) for cytotoxicity. Finally, we exam-
ined the influence of methyl prednisolone, as an inhibitor
of cell injury, on DNA fragmentation, caspase activation,
and secretion of HMGB1 from L. pneumophila-infected
A549 cells.
Methods
Bacterial strains
The virulent AA100jm strain of L. pneumophila and its avir-
ulent dotO mutant have been described previously [5].
The dotO mutation severely impairs intracellular growth
and evasion of the endocytic pathway by the bacterium
[6]. Both L. pneumophila strains were grown on buffered
charcoal yeast-extract agar medium supplemented with α-
ketoglutarate (BCYE-α) at 35°C in a humidified incuba-
tor, and subsequently subcultured in buffered yeast
extract broth supplemented with α-ketoglutarate (BYE-α).
Cell culture
The human alveolar epithelial cell line A549 was main-
tained in RPMI 1640 medium (Nipro, Osaka, Japan) con-
taining 10% heat-inactivated fetal bovine serum
(Biological Industries, Kibbutz Beit Haemek, Israel), at
37°C in humidified air under 5% CO2.
Colony assay
Cultured A549 cells in 24-well plates containing 1.25 ×
105 cells/well were infected with L. pneumophila at a mul-
tiplicity of infection (MOI) of 100. The plates were spun
down at 1,300 revolutions per minute (rpm) (about 150
× g) for 10 minutes. After incubation for 2 hours, the
extracellular fluid and bacteria were removed by washing
3 times with tissue culture medium, and the plates were
further incubated for up to 3 days. At various times, the
cultured cells were desquamated into the supernatant by
gentle scratching with a pipette tip. The supernatant was
finally harvested and diluted appropriately with sterile
distilled water, and subsequently cultured on BCYE-α
agar.
Cytotoxicity assay
A549 cells were infected with L. pneumophila as described
for the colony assay, except for MOIs and incubation
times. At various times after incubation, the culture super-
natants were harvested. Lactate dehydrogenase (LDH) lev-
els were measured in the supernatants as a marker of
cytotoxicity using the LDH-cytotoxic Test Wako (Wako
Pure Chemical Industries, Osaka, Japan), according to the
instructions provided by the manufacturer. The level of
specific cytotoxicity was calculated by the following for-
mula:
% of specific LDH release = ([experimental LDH release - 
the mean of negative control release]/[the mean of posi-
tive control release - the mean of negative control release]) 
× 100.
LDH release from cells treated with 0.05% saponin was
used as a positive control, while the negative control was
LDH release from nontreated cells.Respiratory Research 2008, 9:39 http://respiratory-research.com/content/9/1/39
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Quantitation of high mobility group box 1 (HMGB1) 
protein
A549 cells were infected with L. pneumophila as described
for the colony assay. Two days after infection, the culture
supernatants were harvested. HMGB1 levels in the super-
natants were determined using a sandwich ELISA kit II
(Shino-Test Corporation, Kanagawa, Japan) [16] using
pig HMGB1 as a standard, according to the instructions
provided by the manufacturer. The detection limit was 1
ng/ml.
TUNEL method
The terminal deoxyribonucleotidyl transferase-mediated
triphosphate (dUTP)-biotin nick end labeling (TUNEL)
method [17] was used for detection of DNA fragmenta-
tion of nuclei. A549 cells grown on glass coverslips in 24-
well plates containing 1.25 × 105 cells/well were infected
with L. pneumophila at various MOIs. Positive controls
were treated with 30 μM mitomycin C. After incubation
for 2 days, the glass coverslips were harvested, fixed with
4% paraformaldehyde, and washed with PBS. The cells
were permeabilized with 0.5% Tween 20 and treated with
MEBSTAIN Apoptosis Kit Direct (Medical and Biological
Laboratories Co, Nagoya, Japan). Cells were then treated
with RNase and propidium iodide (PI). The nick end labe-
ling was analyzed with a confocal laser scanning micro-
scope (Fluorview, Olympus, Tokyo). TUNEL positive cells
were also quantitated using flow cytometry (Flow Cytom-
eter, Coulter Corporation, FL).
Colorimetric assay for caspase activity
Commercially available caspase activity assays (Colori-
metric Assay kit; BioVision Research Products, Mountain
View, CA) based on colorimetric detection of cleaved
para-nitroaniline-labeled substrates specific for caspase 3
(DEVD), 8 (IETD), 9 (LEHD), and 1 (YVAD) were used to
analyze caspases activity according to the instructions pro-
vided by the manufacturer. Briefly, A549 cells cultured in
8.5-cm dishes containing 7 × 106/dish were stimulated,
collected, and lysed on ice. Cleaved samples (4 μg/μL),
were incubated at 37°C for 2 hours in the presence of
labeled caspase-specific substrate conjugates for caspase 3,
8, 9, and 1. Caspase activity was determined from the
sample absorbance at 405 nm measured in a microplate
reader (Bio-Rad, Tokyo, Japan).
Western blotting
A549 cells were infected with L. pneumophila or treated
with mitomycin C, in a manner similar to caspase activity
analysis. After 24 hours, the cells were lysed in a buffer
containing 62.5 mM Tris-HCl (pH 6.8), 2% sodium
dodecyl sulfate, 10% glycerol, 6% 2-mercaptoethanol,
and 0.01% bromophenol blue. Equal amounts of protein
(20  μg) were subjected to electrophoresis on sodium
dodecyl sulfate-polyacrylamide gels followed by transfer
to a polyvinylidene difluoride membrane and probing
sequentially with specific antibodies against caspases 8
and 9, and against cleaved poly (ADP-ribose) polymerase
(PARP), which is a natural substrate of caspase 3 (Cell Sig-
naling Technology Inc, Danvers, MA). The bands were vis-
ualized by enhanced chemiluminescence (Amersham
Biosciences, Piscataway, NJ).
Influence of methyl prednisolone on DNA fragmentation, 
caspase activity, and HMGB1 release
A549 cells were pretreated with or without methyl pred-
nisolone (53.4 μM) for one day, and subsequently stimu-
lated. Cells were then further incubated with or without
methyl prednisolone (53.4 μM). DNA fragmentation, cas-
pase activity, and HMGB1 release were assayed in L. pneu-
mophila-infected A549 cells following these treatments.
DNA fragmentation was analyzed by flow cytometry,
while caspase activity and HMGB1 release were deter-
mined as described above.
Statistical analysis
Statistical significances were determined using the
unpaired or paired t-test (for two-category comparison),
or ANOVA and SNK test as post hoc test (for comparison
of more than three parameters). A significant difference
was considered to be P < 0.05.
Results
Intracellular growth and cytotoxicity of L. pneumophila 
in A549 cells
First, we verified the infection and intracellular growth of
L. pneumophila in A549 cells. Intracellular growth of the
virulent strain was observed 1 day after infection, subse-
quently increasing to approximately 100-fold the initial
growth 3 days after infection. In contrast, the avirulent
dotO mutants did not multiply intracellularly and their
growth decreased with time. Cells infected with the two
different strains therefore showed significantly different
viable bacterial burdens from one day after infection (Fig.
1).
To determine the cytotoxic effect of L. pneumophila in
A549 cells, we measured LDH level in the supernatants. As
for LDH levels, time-dependent and MOI dose-dependent
increases of cytotoxicity in the AA100jm-infected A549
cells were significantly observed, compared to those in the
dotO  mutant-infected cells (Fig. 2a and 2b). A newly
defined cytokine, HMGB1 is reported to be released dur-
ing cell death. MOI dose-dependent significant increases
of HMGB1 concentration were observed in A549 cells
infected with virulent strain, compared to those in cells
infected with the avirulent strain (Fig. 3).Respiratory Research 2008, 9:39 http://respiratory-research.com/content/9/1/39
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Nuclear DNA fragmentation of L. pneumophila-infected 
A549 cells
We investigated nuclear DNA fragmentation in infected
A549 cells as a possible mechanism of L. pneumophila-
induced cytotoxicity by TUNEL staining. A549 cells
infected with the virulent strain of L. pneumophila,
AA100jm, showed significantly more nuclear DNA frag-
mentation than those carrying the avirulent dotO mutant
strain (Fig. 4a–h and Fig. 5). The fragmentation also
increased dose-dependently with MOI in the AA100jm-
infected cells (Fig. 4a–d and Fig. 5). Furthermore, these
results were replicated in flow-cytometry analyses of
infected A549 cells (Fig. 6a and 6b).
Caspase activity in L. pneumophila-infected A549 cells
Caspase activation is essential for DNA fragmentation in
apoptosis induced by a variety of stimuli [18,19]. We
therefore measured the activity of various caspases in L.
pneumophila-infected A549 cells colorimetrically. A549
cells infected with the virulent AA100jm strain had signif-
icantly elevated caspase 3, 8, 9, and 1 activities compared
to those infected with the dotO mutant bacteria (Fig. 7a–
d). To further demonstrate caspase activity in L. pneu-
mophila-infected A549 cells, we examined the cleavage
activation of various caspases by western blot analysis.
These experiments confirmed cleaved products of caspase
8, and 9, and the natural substrate of caspase 3, PARP, in
HMGB1 release from A549 cells induced by L. pneumophila  infection Figure 3
HMGB1 release from A549 cells induced by L. pneu-
mophila infection. A549 cells were infected with L. pneu-
mophila virulent AA100jm and avirulent dotO mutant strains. 
After incubation, HMGB1 levels in the supernatant showed 
an MOI dose-response relationship 2 days after infection. 
Symbols : h, virulent strain AA100jm; ▪, avirulent strain dotO 
mutant. Data are mean ± SD of three wells. * P < 0.05.
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Intracellular growth of L. pneumophila in A549 cells Figure 1
Intracellular growth of L. pneumophila in A549 cells. 
A549 cells were infected with L. pneumophila virulent 
AA100jm and avirulent dotO mutant strains at an MOI of 100. 
After 2 hours incubation, extracellular bacteria were 
removed by washing, and the infected cells were cultured 
further. The number of viable bacteria in each well was 
determined by the CFU counting method. Symbols : h, viru-
lent strain AA100jm; ▪, avirulent strain dotO mutant. Data are 
mean ± SD of four wells. * P < 0.05.
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Cytotoxic effect of L. pneumophila on A549 cells Figure 2
Cytotoxic effect of L. pneumophila on A549 cells. A549 
cells were infected with L. pneumophila virulent AA100jm and 
avirulent dotO mutant strains. LDH levels in the cell superna-
tants showed a time-dependent change after infection with L. 
pneumophila at an MOI of 20 (A), and an MOI dose-response 
relationship 2 days after infection (B). Symbols : h, virulent 
strain AA100jm; ▪, avirulent strain dotO mutant. Data are 
mean ± SD of three wells. * P < 0.05.
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cells infected with the virulent strain of L. pneumophila
(Fig. 8).
Inhibition of nuclear DNA fragmentation, caspase 
activation, and HMGB1 release in A549 cells by methyl 
prednisolone
Glucocorticoid-induced antiapoptotic signaling was
recently associated with resistance to apoptosis in cells of
epithelial origin [20]. We found that methyl prednisolone
partly inhibited DNA fragmentation (Fig. 9a and 9b), as
well as significantly reducing caspase 3, 8, 9, and 1 activi-
ties (Fig. 10a–d) and HMGB1 release (Fig. 11) in
AA100jm-infected cells.
Discussion
Cell death is typically discussed as necrosis, apoptosis, or
pyroptosis. While necrosis is characterized as accidental
cell death due to physical damage, apoptosis is a strictly
regulated genetic and biochemical suicide program that is
critical during development and tissue homeostasis, and
in modulating the pathogenesis of a variety of diseases
[21]. A number of pathogens cause host cell death with
features of apoptosis [22-24]. Pyroptosis is a recently
described type of cell death, in which caspase 1 is acti-
vated and inflammatory cytokines are released as cells are
dying [25].
Several previous studies investigated the induction of
apoptosis correlated with cytotoxicity in Legionella-
Nuclear DNA fragmentation of L. pneumophila-infected A549 cells detected by the TUNEL method Figure 4
Nuclear DNA fragmentation of L. pneumophila-infected A549 cells detected by the TUNEL method. MOI dose-
response relationship of nuclear DNA fragmentations 2 days after infection with the virulent AA100jm strain (A-D) and the 
avirulent dotO mutant strain (E-H). Nuclear DNA fragmentation of cells 2 days after exposure to 30 μM mitomycin C (I) and 
with no treatment (control) (J). Cells were observed with a confocal laser scanning microscopy (all 200 ×). The nuclear DNA 
fragmentation is shown in green (FITC staining), and A549 cell nuclei in red (PI staining).
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infected cells [26,27,14]. The present study confirmed
that L. pneumophila multiply within A549 alveolar epithe-
lial cells, resulting in cytotoxicity. We investigated the
mechanism by which L. pneumophila induces cell injury in
A549 cells by the TUNEL method using both confocal
laser scanning microscopy and flow cytometric analysis to
assess DNA fragmentation at the single cell level. We also
assayed caspase activation using colorimetric assays and
western blotting. Chromosomal DNA fragmentation that
increased dose-dependently with MOI, and the activation
of caspase 3, 8, and 9, indicated that some alveolar epithe-
lial cell injury induced by L. pneumophila was attributable
to apoptosis. The results suggested that activation of cas-
pase 1 within alveolar epithelial cells might also be
involved.
The L. pneumophila mutant strain carrying a defective dot/
icm system failed to induce chromosomal DNA fragmen-
tation or caspase activation in A549 cells. However, fur-
ther studies are needed to ascertain whether the induction
of apoptosis in these cells following L. pneumophila infec-
tion is dependent on the dot/icm system itself or on the
intracellular growth capacity of the bacteria. Gross et al.
[28] suggested that certain intracellular bacteria might
inhibit apoptosis to enhance their own survival, thus
boosting replication within phagocytes and their contin-
ued presence at sites of infection. Another group of bacte-
Analysis of the nuclear DNA fragmentation in L. pneumophila- infected A549 cells by flow cytometry Figure 6
Analysis of the nuclear DNA fragmentation in L. 
pneumophila-infected A549 cells by flow cytometry. 
Two days after treatment, A549 cells were treated for 
TUNEL staining and the nuclear DNA fragmentation was 
analyzed by flow cytometry. A549 cells infected with the vir-
ulent AA100jm (A) and the avirulent dotO mutant (B) strains 
at an MOI of 100, exposed to 30 μM mitomycin C (C), or 
not stimulated (control) (D) are shown. The nuclear DNA 
fragmentation is expressed as FITC staining intensity. FS indi-
cates the cell sizes.
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Nuclear DNA fragmentation of L. pneumophila-infected A549  cells detected by the TUNEL method Figure 5
Nuclear DNA fragmentation of L. pneumophila-
infected A549 cells detected by the TUNEL method. 
TUNEL-positive A549 cell numbers with each stimulus are 
presented. Cells were observed with a confocal laser scan-
ning microscopy. More than 500 cells were counted from 10 
randomized high-power fields, and TUNEL-positive cells 
were expressed as a ratio per total number of cells. Symbols: 
h, virulent strain AA100jm; ▪, avirulent strain dotO mutant. 
Data are mean ± SD of three different experiments. * P < 
0.05.
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Caspase activity in L. pneumophila-infected A549 cells  detected by colorimetric assay Figure 7
Caspase activity in L. pneumophila-infected A549 cells 
detected by colorimetric assay. One day after stimula-
tion, infection with the virulent strain AA100jm and the avir-
ulent strain dotO mutant at an MOI of 400, expose to 30 μM 
mitomycin C and no-stimulation (control), caspases activity 
of each cell-group was detected by colorimetric assay. The 
activities of caspase 3 (A), 8 (B), 9 (C), and 1 (D) are shown. 
Data are mean ± SD of five or six different experiments. * P 
< 0.05.
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ria including L. pneumophila promotes the apoptosis of
phagocytes, resulting in either control of intracellular
growth of the bacteria or evasion of the immune system
[14]. Based on the results of the present study, it is difficult
to tell whether caspase activation in alveolar epithelial
cells works to regulate or augment the infection. Further
study is clearly warranted to pursue this proposition.
The caspase family of cysteine proteases is important in
regulating apoptosis and the inflammatory response [29].
Caspase 3, main executioner caspase, is specifically
required for DNA fragmentation leading to the typical
apoptotic pattern of DNA laddering [30-32]. Otherwise,
initiator caspases appear to be activated by many apopto-
sis-inducing stimuli via two major pathways: the death
receptor pathway and the mitochondrial/apoptosome
pathway [33]. The regulatory protein caspase 8 is directly
activated by death receptors, while caspase 9 activation
follows mitochondrial stress [34,35]. Our results here
demonstrated for the first time that L. pneumophila
induced caspase-dependent cell injury in A549 cells with
elevations in caspase 3, 8, and 9 activities. Gao and Abu
[36] demonstrated that the induction of apoptosis by L.
pneumophila in macrophages is mediated through activa-
tion of caspase 3, while Fischer et al. [37] similarly impli-
cated caspase 9 and 3 in myeloid cells and T cells.
Some caspases, such as caspase 1, are also important com-
ponents of signaling pathways associated with the
immune response to microbial pathogens. Caspase 1 acti-
vation is associated with the maturation of pro-inflamma-
tory cytokines, such as interleukin-1β (IL-1β) and IL-18,
but not apoptosis per se [38]. Recent studies on Shigella
and Salmonella infections implicated caspase 1 activation
in programmed cell death [38,39] that was different from
apoptosis induced by the activation of caspase 3 [40]; this
process was named pyroptosis [25]. Our present study
found that caspase 1 was activated by L. pneumophila infec-
tion in A549 alveolar epithelial cells, suggesting a correla-
tion with the cytopathic effect on the cells.
This is the first description also of increased HMGB1 pro-
tein in the supernatants of alveolar epithelial cells infected
with virulent L. pneumophila. HMGB1 is a non-histone
nuclear protein with dual function. Inside the cell,
HMGB1 binds DNA and regulates transcription, whereas
it acts as a cytokine outside the cell [41,42]. HMGB1 leaks
out from necrotic cells and signals to neighboring cells
that tissue damage has occurred [43], and recent reports
indicate that HMGB1 might also be released during apop-
tosis [44]. Therefore, HMGB1 protein is a cytokine
released from dying cells, but it is not clear which type(s)
of cell death is associated with release of HMGB1 from
Legionella-infected alveolar epithelium. In this study, the
increased LDH and HMGB1 secreted from AA100jm-
Influence of methyl prednisolone on the nuclear DNA frag- mentation of L. pneumophila-infected A549 cells Figure 9
Influence of methyl prednisolone on the nuclear 
DNA fragmentation of L. pneumophila-infected A549 
cells. Cells were pre-treated with and without methyl pred-
nisolone (53.4 μM) for one day, and subsequently stimulated. 
After a 2-day incubation, nuclear DNA fragmentation stained 
by the TUNEL method was analyzed by flow cytometry. The 
nuclear DNA fragmentation of virulent strain AA100jm-
infected cells without (A) and with methyl prednisolone (B), 
is shown with no-pretreatment/no-stimulation cells (control) 
(C), and 30 μM mitomycin C-exposed cells without (D) and 
with methyl prednisolone (E). FS indicates the cell sizes. m-P; 
methyl prednisolone.
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Caspase activity in L. pneumophila-infected A549 cells  detected by western blotting Figure 8
Caspase activity in L. pneumophila-infected A549 cells 
detected by western blotting. Cells treated as for the 
colorimetric assay were subjected to western blotting. 
Cleavage activations of caspase 8, 9, and poly (ADP-ribose) 
polymerase (PARP; natural substrate of caspase 3) were 
detected.
AA100jm
dotO
mutant control mitomycin C
cleaved caspase-8
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infected A549 cells was dependent on the MOI and corre-
lated with an increase in TUNEL-positive cells. This find-
ing suggests a link between HMGB1 release from dying
cells and caspase activation.
Glucocorticoids have a dual effect on apoptosis. Cells of
hematopoietic origin such as monocytes, macrophages,
lymphocytes, and lymphoma cells are very sensitive to
glucocorticoid stimulation of apoptosis [20]. In addition,
recent studies associated glucocorticoid-induced anti-
apoptotic signaling with apoptosis resistance in trans-
formed cells of epithelial origin [20,45]. We also con-
firmed that chromosomal DNA fragmentation of
AA100jm-infected A549 cells is inhibited by methyl pred-
nisolone, and that this inhibition of cell injury is accom-
panied by the degradation of caspase 3, 8, and 9. We
therefore postulate that the inhibition of caspase-depend-
ent cell injury by methyl prednisolone resulted at least
partly from the depressed death receptor and mitochon-
drial signaling. Moreover, we detected inhibition of cas-
pase 1 in our experiments, which probably related to
signaling pathways associated with immune responses to
microbial pathogens.
The present in vitro study showed potential pathogenesis
of L. pneumophila against human alveolar epithelial cells.
L. pneumophila clearly induced the damage of alveolar epi-
thelial cells in dose-dependent and time-dependent man-
ners. The administration of methyl prednisolone at the
early stage of L. pneumophila infection may decrease apop-
tosis in alveolar epithelial cells. Clinical significance of
alveolar epithelial cells infection has been pointed out
with other Legionella spp., such as Legionella dumoffii [46],
but its role in L. pneumophila infection is not so clear. The
present findings warrant further in vivo animal studies and
human studies.
Conclusion
Infection of A549 alveolar epithelial cells by L. pneu-
mophila caused cell death, nuclear DNA fragmentation,
activation of various caspases, and release of HMGB1. The
dot/icm system was identified as a major virulence factor
for the effects of L. pneumophila on these cells. This study
suggested that the cytopathic effect of L. pneumophila on
A549 alveolar epithelial cells is mediated via activation of
caspase 3, 8, 9, and 1. Therefore, the mode of cell death
could be apoptosis and/or pyroptosis, induced by either
death-receptor signaling or mitochondrial stress. In this
study, methyl prednisolone had an anti-apoptotic effect
on alveolar epithelial cells infected with bacteria. The
search for substances that modulate the interaction
between alveolar epithelial cells and Legionella  may be
warranted as a novel therapeutic intervention.
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Influence of methyl prednisolone on HMGB1 release from L.  pneumophila-infected A549 cells Figure 11
Influence of methyl prednisolone on HMGB1 release 
from L. pneumophila-infected A549 cells. Cells were 
pre-treated with and without methyl prednisolone (53.4 μM) 
for one day, and subsequently infected with the virulent 
AA100jm strain of L. pneumophila. After another day, 
HMGB1 release was measured in cell supernatants. Symbols: 
h, without methyl prednisolone; ▪, with methyl prednisolone. 
Data are mean ± SD of three different experiments. * P < 
0.05.
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Influence of methyl prednisolone on caspase activity in L.  pneumophila-infected A549 cells Figure 10
Influence of methyl prednisolone on caspase activity 
in L. pneumophila-infected A549 cells. Cells were pre-
treated with and without methyl prednisolone (53.4 μM) for 
one day, and subsequently stimulated. After a 1-day incuba-
tion, caspases activity was measured colorimetrically. The 
activities of caspase 3 (A), 8 (B), 9 (C), and 1 (D) are pre-
sented. Data are mean ± SD of four or six different experi-
ments. * P < 0.05. m-P; methyl prednisolone.
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